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Liver Trans antat on with Incidental
Gallbladder Carcinoma in the Recipient
Hepatectomy
W.KENNETHWASHBURN, W.DAVIDLEWIS and ROGER L.JENKINS
The Division of Liver Transplantation and Hepatobiliary Surgery, New England Deaconess Hospital, Boston, MA
Gallbladder carcinoma(GBCA) is the mostcommon malignancy ofthe biliary tract and is often
found seredipitiously aftercholecystectomy.We report the first two cases ofincidentalGBCA in the
native gallbladder oftwo liver transplant recipients. Both patients are 2.5 years following uneventful
orthotopiic liver transplantation(OLTx) with no evidence ofrecurrent disease. Pathology ofboth
recipientswas earlyand favorable. Neither patient received any further therapy. Given the incidence
ofGBCA and the evolution ofOLTxwewould anticipate this finding to bemore prevalent.
KEYWORDS: Liver transplant Gallbladder neoplasms
INTRODUCTION
Surgeons performing biliary tract surgery will encounter
GBCA 1-2% of the time. Most long term survivors
of GBCA had incidental discovery of the malignancy,
with cholecystectomy as the only surgical therapy.3-6
Though some authors favor aggressive resection for early
GBCA,7- most agree that there is little role for curative
surgery in the more advanced stages ofthis disease. OLTx
has assumed amuchmore limited ifnot non-existant role
in the treatment ofbiliary tract malignancies, most nota-
bly cholangiocarcinoma. Recurrence rates are extra-
ordinarily high and most patients succumb to recurrent
disease. Five year survival in most series is at best 20/o.l
OLTx has not been a treatment modality for GBCA
because of the advance stage, of disease in which most
patients present and the propensity for local lymphatic
spread. 12 However, given thatGBCA isfound incidently in
1-2% ofcases ofbiliary tract surgery,3 this finding should
occur with a similar frequency duringOLTx. To date, we
believe there have been no reported cases of incidental
GBCA in the recipient hepatectomy specimen.We report
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here two patients who underwent OLTx who had
incidental findings ofGBCA in their native liver.
CASE REPORT
The first patient is a 53 year old femalewho underwent an
uneventfullOLTx on 8/11/91 forprimary biliary cirrhosis.
She is maintained on FK506-PRED. There was no gross
abnormality of her native gallbladder noted at surgery.
Her pathology revealed the native gallbladder to have
extensive adenomatous hyperplasia with foci ofwell diffe-
rentiated adenocarcinoma(TiNoM0,AJCC stage 1). There
was no muscular invasion and all lymph nodes were
negative for metastatic disease. There were 15 stones
measuring 1.0cm in diameter found in the specimen. Her
post-operative course was uneventful. She remains well
with normal graft function and no evidence ofdisease 2.5
years following her transplant.
The second patient is a 65 year oldmalewho underwent
OLTx on 7/6/91 for primary sclerosing cholangitis. He is
maintained on FK506-PRED. Pre-operative ultrasound
revealed the gallbladder to be thickened but no evidence
ofany mass lesions. There were no abnormalities noted at
the time of surgery. There was a papillary growth at the
fundus ofthe gallbladder noted on pathologic examina-
tion which revealed adenocarcinoma with extension in
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the advential soft tissue and no evidence oflymph node
involvement(T2NoM0, AJCC stage 11). There was no
evidence ofgallstones. He remains well 2.5 years following
transplantation with no evidence ofdisease.
DISCUSSION
GBCA remains one ofthe most fatal malignancies ofthe
G1 tract with 5 year survival inmost series only 5-10%. The
incidence of GBCA has been calculated to be 2.5 per
100,00 inhabitants.9 This incidence is increased to 1-2% in
patients undergoing biliary tract surgery.2,9,2 The peak
incidence is usually in the seventh decade oflife?-
Choleli-
thiasis is found in 60-80% ofcases ofGBCA,2 thoughno
direct causative effect has yet been identified. Histolo-
gically, adenocarcinoma is the most common type with
papillary carcinoma having themost favorable prognosis.
Lymphatic and/or vascular invasion are indicative ofa less
favorable outcome. Surgical treatment is often palliative as
most cases ofGBCA at presentation are beyond the scope
ofa curative resection. Those patientswho did enjoy long
term survival often had the malignancy discovered inci-
dently at the time ofcholecystectomy.4,6,17,18 Though this
scenario is infrequent(1% of all CCY), controversy con-
tinues to exist with regards to the treatment of those
patients with incidentalGBCA. Cholecystectomy alone is
often considered adequate surgical management for non-
invasiveT GBCA. 13-6 Radical resection formore advan-
ced node negative disease has been advocated by
Shirai et al. They perform a wedge resection of the
gallbladder bed withlymph node dissection and excision
of the supraduodenal extra-hepatic biliary tree for T
lesions(invades perimuscular connective tissue with no
extension beyond the serosa). With this approach they
have extended the 5 year survival from40% to 90%. They
found no survival advantage toT lesions (confined to the
mucosa) treated with radical resection.
OLTx has become a successful treatment for patients
with end-stage liver disease with one year survival inmost
programs75-80%. Reports ofOLTx formostmalignancies
including cholangiocarcinoma and large primary hepa-
tomas have universely shown extremelypoor survival with
extraordinarily high recurrence rates and most patients
II 23 25 succumbing to their native disease. Five year survival
for patients transplanted for cholangiocarcinoma isjust
17%.t There are no reports ofOLTx forprimaryGBCA,
nor are there any reports ofincidental findings ofGBCA
in the recipient hepatectomy specimen. Given the
generally dismal prognosis for GBCA when it is not
incidentally found, it is not surprising thatOLTx is not a
therapeutic option for patients with this disease. However,
given the incidence ofGBCA found in patients under-
going biliary tract surgery, one would anticipate the
finding of incidental GBCA to be somewhat similar in
patients undergoing OLTx. This incidence will likely be
somewhat less considering the pediatric population and
theyounger age ofmostOLTx patientscompared with the
peak incidence ofGBCA in the seventh decade of life in
the general population.
The dissection forOLTx does notencompass the nodal
drainage ofthe gallbladder nor does it routinely result in
excision ofthe extra-hepatic biliary tree as is done in the
radical re-resection advocated by Shirai. As an incidental
finding in the recipient gallbladder, these patients can be
observed without other intervention. Neoadjuvant
therapy has been extremely disappointing with minimal
response rates.26 Without evidence of more extensive
disease (T2) there is no need to consider further surgical
intervention.
We report the firsttwo cases ofincidentalGBCAfound
in the recipient hepatectomy specimen of patients
undergoing OLTx. Both patients remain alive and well
with NED 2.5 years after transplantation. Given the
frequency ofGBCA andOLTxwe expect this entity to be
more common. With early lesions, as most incidental
GBCA are, little else need be done besides the routine
follow-up. Ifthe incidentalGBCA is ofamore advanced
stage then one should consider re-resection ofthe biliary
tree and regional lymph node dissection. However, liver
transplantation is not a therapeutic option for incidental
GBCA found in the non-transplant patient.
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